| Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer |
PAR-22-061 (R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
01/08/2025 |
Young Kim, Ph.D. |
| Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) |
NOT-OD-22-202 |
|
Clinical Trial Not Allowed |
04/16/2025 |
Nancy J. Emenaker, Ph.D., RDN, LD, FAND |
| Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases |
NOT-DA-22-048 |
|
|
01/08/2026 |
Sharon Ross, Ph.D., M.P.H. |
| Notice of Special Interest (NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention and Cancer Interception Research |
NOT-CA-24-074 |
|
|
01/08/2027 |
Nancy J. Emenaker, Ph.D., RDN, LD, FAND |
| Enhancing Mechanistic Research on Precision Probiotic Therapies |
PAR-25-211 (R61/R33 Clinical Trial Optional) |
R61, R33 |
Clinical Trial Optional |
06/03/2027 |
Gabriela Riscuta, M.D., CNS |